A 73-year-old woman with liver cirrhosis caused by hepatitis C virus (HCV) underwent treatment of three hepatocellular carcinomas (HCCs) in liver segment 4, following three previous laparoscopic liver resections (LLRs) over 73 months. Contrast-enhanced computed tomography showed three 0.5-1.2 cm HCCs deep within the portal territories of subsegments 4a and 4b. The patient underwent laparoscopic resection of 4a and 4b, with the preservation of the portal branch to 4c, after minimal adhesiolysis around segment 4. The operation lasted 284 min, there was 50 mL of intra-operative bleeding and her recovery was uneventful. She was well, had experienced no recurrence and was HCV-negative, after taking oral anti-HCV therapy, 21 months later. LLR is associated with fewer adhesions after surgery and requires less adhesiolysis, because the laparoscope and forceps can be used in the small spaces between adhesions. The present patient underwent four LLRs over 6 years without severe deterioration of liver functional reserve. LLR is a useful localized therapy, which can be performed repeatedly and may prolong the survival of patients with multicentric metachronous HCCs.
INTRODUCTION
Since the first successful report of laparoscopic liver wedge resection in 1991, [1] laparoscopic liver resection (LLR) has been thought to be a "less invasive" procedure than open liver resection. Use of this technique is especially beneficial for patients with concurrent hepatocellular carcinoma (HCC) and chronic liver disease (CLD). [2] [3] [4] However, accumulated experience of this technique and technological developments have facilitated the expansion of the indications for LLR. [5] [6] [7] It is becoming clear that the magnified caudal view offered by laparoscopy allows improved visualization, especially for the hilar and dorsal area of the liver, and is thus beneficial for the dissection of hilar Glissonian pedicles and the inferior vena cava (IVC). [7] [8] [9] LLRs of major hepatectomy and, even, with combined resection of major hepatic veins are now increasingly reported, [10] [11] [12] despite the latter previously being a contraindication. Reports of repeated LLR procedures [13] [14] [15] [16] are also increasing. However, these reports have generally included both cases of HCC with CLD and of metastatic disease without background liver disease. [17] [18] [19] [20] [21] The indication and efficacy of repeated LLR for HCC in a setting of CLD alone has yet to be fully determined. Here we present a case report of a fourth LLR for recurrent HCCs in cirrhotic liver and review the previously reported cases of repeat LLR for the treatment of HCC. [22, 23] 
CASE REPORT
A 73-year-old woman with hepatitis C virus (HCV)-related liver cirrhosis (LC) was admitted to our department for treatment of three lesions in liver segment 4. These were revealed by contrast-enhanced computed tomography (CT) examination undertaken during the follow up to three LLRs that were performed 73, 45, 23 months previously [ Figure 1 ]. The patient had no history of hepatic encephalopathy, ascites (except immediately postoperatively) and no specific treatment history except that of the liver disease.
The laboratory data showed decreased white blood cell and platelet counts (1,800 and 68,000/µL, respectively) and plasma albumin (3.5 g/dL) and mild elevations in plasma aspartate transaminase (AST, 76 IU/L) and alanine transaminase (ALT, 71 IU/L). The prothrombin time (78%), plasma levels of total bilirubin (0.6 mg/dL) and prothrombin induced by vitamin K absence-II (PIVKA-II, 9 mAU/mL) were within their normal ranges, but alpha-fetoprotein (AFP) showed a mild elevation (to 67.5 ng/mL). The 15-min value during the clearance rate of indocyanine green loading test (ICG-R15) was 24.1%; this had not deteriorated over the 73 months since the first LLR [ Table 1 ]. 
A B C
CT demonstrated three 0.5-1.2-cm-sized low-density lesions in the deeper region of liver segment 4, within the portal territories of subsegments 4a and 4b. The lesions were enhanced with contrast during the arterial phase and washout of the enhancement was observed in the portal-venous phase [ Figure 2 ]. Laparoscopic anatomical resection of subsegments 4a and 4b were planned, with the preservation of the portal branch to 4c on the bottom of the resection plane. This procedure would ensure a surgical margin appropriate to the diagnosis of multiple HCCs in cirrhotic liver, given the possibility for the removal of tumor cell dissemination in the portal territory, but also preserve the maximum possible liver volume [ Figure 2 ].
During the surgery, the patient was placed in a supine position. The first trocar port was introduced by minilaparotomy on the umbilicus; CO 2 -pneumoperitonium (8-12 mmHg) was established through this port and it was also used for laparoscopy. Three other 12-mm ports and one 8-mm port were placed in the left upper abdomen and used for introducing surgeons' forceps, electrical devices (SonoSurg ® , BiClamp ® bipolar forceps and irrigation monopolar electrical cautery using soft-mode coagulation), clips and a Cavitron ultrasonic surgical Transection of the liver parenchyma was commenced to the right of the line of the umbilical plate [ Figure 3B ]. During the transection, the Glissonian branches supplying subsegments 4a, and subsequently 4b, were encircled and divided [ Figure 3C ]. After dividing the branches to 4a and 4b, the area containing the HCCs was clearly recognized as an ischemic area, in advance of resection [ Figure 3D ]. The ischemic area was resected laparoscopically, leaving the Glissonian branch to subsegment 4c exposed deep to the transection plane [ Figure 4A ]. The operation took 284 min and 50 mL of blood was lost intra-operatively.
Pathological examination of the three tumors identified them to be well-differentiated HCCs with fibrous capsules, but without vessel invasion, surrounded by grade F4 liver cirrhosis [ Figure 4 ].
The patient recovered uneventfully and she was well, without recurrence, 21 months after surgery. Furthermore, she was then HCV-negative, having been taking a newly developed oral anti-HCV therapy (Daclatasvir/Asunaprevir).
DISCUSSION
The development of post-operative adhesion is known to increase the surgical time in subsequent surgeries, as a result of the need for adhesiolysis, the risk of intraoperative complications [24] and the possibility of conversion from laparoscopic procedure to laparotomy. [25] Although a history of abdominal surgery had been considered a contraindication for laparoscopic surgery in the early days of the procedure, improvements in technique and instrumentation have more recently permitted many laparoscopic procedures to be safely applied to such patients. [24, [26] [27] [28] [29] However, LLR remains a technically demanding procedure and the indications for and efficacy of repeat LLRs are still under discussion. Successful liver resection requires adequate adhesiolysis and mobilization of the involved liver area. Adhesions can be obstacles to the visualization and dissection of the hepatoduodenal ligament and hilar area, which are often crucial steps in LLR. Liver capsule bleeds easily during adhesiolysis and mobilization, creating a suboptimal surgical field, in addition to the increase in blood loss. [30] The outcomes of repeated LLRs have been reported in several small case series. [13] [14] [15] [16] However, these studies often included both HCC/CLD and metastatic patients, [17] [18] [19] [20] [21] while the clinical settings for repeated LLR are quite different in HCC/CLD and metastatic patients. Patients with metastasis sometimes undergo major liver resection involving the handling of Glissonian pedicles in soft, congested and/or fatty parenchyma. Conversely, HCC/CLD patients often undergo minor resection of the hard, fibrotic liver, which has a poor functional reserve and is surrounded by blood or lymphatic collateral vessels, which should be preserved. The number of reported repeat LLR cases for HCC/LLR patients is very small, and these are summarized in Table 2 .
There are three previous reports of repeat LLR focused for HCC/CLD patients. Belli et al., [13] Hu et al., [15] and Kanazawa et al. [22] reported 12, 6, and 20 cases, respectively. They all concluded that repeat LLR for recurrent HCC in cirrhotic patients is a safe and feasible procedure. Belli et al. [13] reported that the surgical time for repeat LLR was shorter and the adhesiolysis was easier for patients previously treated using LLR compared to open LR (OLR), and also detailed the advantages of the minimally invasive approach for managing the chronic oncologic sequelae of cirrhosis. Kanazawa et al. [22] compared repeat LLR to repeat OLR in n = 20 groups of patients and concluded that postoperative morbidity and the duration of postoperative hospitalization have been decreased by the introduction of LLR for patients with recurrent HCC.
We previously reported that LLR is useful for patients with severe liver dysfunction, as it minimizes disturbance of the collateral blood/lymphatic flow caused by laparotomy and liver mobilization, and the mesenchymal injury caused by compression of the liver. [31, 32] Thus, LLR limits the occurrence of complications, such as massive ascites, which can lead to postoperative liver failure. [3] We also reported that the smaller working space required for LLR necessitated less adhesiolysis, with a direct approach to the region affected by the tumor being possible in repeat LLR. [20] This also meant that patients undergoing repeat LLR had similar perioperative results to patients without a history of surgery, especially in the case of minor resections for HCC/CLD patients. The majority of the patients described in previous reports of repeat LLR for HCC/CLD underwent minor resection as a repeat LLR. Therefore the influences of alterations to hilar and intrahepatic anatomy from the first hepatectomy should have been relatively small. Since alterations in hilar and intrahepatic vascular supply would greatly impact on the second hepatectomy, further consideration of a role for major or anatomical repeat LLR is needed. However, results to date suggest that a clear advantage of LLR for minor repeat resections of impaired liver is that it only requires minimal adhesiolysis.
In the case reported here, the patient underwent four LLRs over six years without severe deterioration of liver functional reserve, represented by the A B C ICG-R15, and became HCV-negative, after taking a newly developed oral anti-HCV therapy. The patient remained in compensated LC throughout the period in which the four LLRs were performed. As a result, and because of the shortage of cadaver donors in Japan, liver transplantation was not undertaken. During both the first and fourth LLRs, minor anatomical resections (extended segment 3 segmentectomy and 4ab subsegmentectomy, respectively) were undertaken to remove multiple tumors in the same portal territories, because the patient's liver functional reserve (estimated by ICGR15) was insufficient to support sectionectomy or more extended resection. Furthermore, ablation therapy was not performed for the protuberant tumors necessitating the first and second LLRs and for the tumor adjacent to the IVC at the time of third LLR, owing to the technical challenges associated. Transarterial chemo-embolization (TACE) was used prior to the third LLR, but the target tumor had regrown six months after TACE; therefore, LLR was selected for the follow-up treatment.
LLR is highly suitable for repeated laparoscopic partial or local anatomical LR for the treatment of multicentric metachronous HCCs within impaired liver and for surface HCC in severe LC. [31, 32] The deterioration of liver function should be minimized with the reduced adhesiolysis and dissection required during a laparoscopic approach. In addition, LLR better prepared patients both physically and psychologically for a subsequent repeat LR, illustrated by a shortened hospital stay for the patient reported here. Thus, LLR is a powerful localized therapy which can be applied repeatedly and may prolong the survival of patients with multicentric metachronous HCCs/CLD.
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